Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome
Status:
Recruiting
Trial end date:
2031-06-01
Target enrollment:
Participant gender:
Summary
The study is a Randomised Registry-based Clinical Trial (RRCT) to assess whether dual
antiplatelet therapy with ticagrelor and ASA compared to ASA alone improves outcome after
isolated CABG in patients with acute coronary syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Vastra Gotaland Region
Collaborators:
Gothia Forum Gothia Forum - Center for Clinical Trial Uppsala University